Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
GLIDABET
BRANDED
The main mechanism of action of gliclazide is by increasing insulin secretion by pancreatic beta cells.
Available at :
Share this article
Related
Articles
Are Stem Cells Potentially Effective in Type 1 Diabetes?
by dr. Hastarita Lawrenti | 25 Jul 2025
Efficacy and Safety of Second-Generation Basal Insulin in DM Patients with Impaired Renal Function
by dr. Alfredo Bambang, MBA | 24 Jul 2025
Pregabalin Appropriate for Diabetic Peripheral Neuropathy Patients with Higher HbA1c, Study Finds
by dr. Hastarita Lawrenti | 01 Jul 2025
.
by dr. Hastarita Lawrenti | 12 Mar 2025
Strategies for Managing Type 2 Diabetes with FRC Iglarlixi During Ramadan Fasting
by dr. Risya Malida | 18 Feb 2025
Potential Use of Stem Cells in Type 2 Diabetes Mellitus Patients
by dr. Hastarita Lawrenti | 21 Mar 2025
Effectiveness of IGlarLixi in Improving Glycemic Control Based on Continuous Glucose Monitoring
by dr. Alfredo Bambang, MBA | 20 Dec 2024
RESTORE-G Data: 40% of T2DM Patients on GLP-1 RA Require Intensification After 2 Years
by dr. Alfredo Bambang, MBA | 17 Dec 2024
Benefits of Exercise for People with Type 2 Diabetes Mellitus
by dr. Vivian Keung | 15 Nov 2024
Cardiovascular Risk in Diabetes and Prediabetes and the Role of Influenza Vaccines
by dr. Reza Adrian | 03 Sep 2024
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE